本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibikase Therapeutics, Inc.

1.85
-0.1250-6.35%
盘后:1.83-0.0150-0.81%19:30 EDT
成交量:74.14万
成交额:136.41万
市值:2.58亿
市盈率:-4.26
高:1.95
开:1.95
低:1.77
收:1.97
52周最高:2.61
52周最低:1.33
股本:1.40亿
流通股本:6,452.05万
量比:1.62
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-0.4327
每股收益(LYR):-0.4909
净资产收益率:-51.96%
总资产收益率:-32.79%
市净率:1.68
市盈率(LYR):-3.76

数据加载中...

2024/10/09

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/06/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report